Literature DB >> 6772061

Is there a therapeutic role for blood-brain barrier disruption?

E A Neuwelt, E P Frenkel.   

Abstract

Mesh:

Substances:

Year:  1980        PMID: 6772061     DOI: 10.7326/0003-4819-93-1-137

Source DB:  PubMed          Journal:  Ann Intern Med        ISSN: 0003-4819            Impact factor:   25.391


× No keyword cloud information.
  6 in total

1.  Chemotherapy administered in conjunction with osmotic blood-brain barrier modification in patients with brain metastases.

Authors:  E A Neuwelt; S A Dahlborg
Journal:  J Neurooncol       Date:  1987       Impact factor: 4.130

2.  Characterization of a new model of GM2-gangliosidosis (Sandhoff's disease) in Korat cats.

Authors:  E A Neuwelt; W G Johnson; N K Blank; M A Pagel; C Maslen-McClure; M J McClure; P M Wu
Journal:  J Clin Invest       Date:  1985-08       Impact factor: 14.808

3.  Concentrations of trimethoprim and sulfamethoxazole in cerebrospinal fluid and serum in mares with and without a dimethyl sulfoxide pretreatment.

Authors:  S L Green; I G Mayhew; M P Brown; R R Gronwall; G Montieth
Journal:  Can J Vet Res       Date:  1990-04       Impact factor: 1.310

4.  Radioimmunolocalization of human brain tumours: biodistribution of radiolabelled monoclonal antibody UJ13A.

Authors:  R B Richardson; A G Davies; S P Bourne; G E Staddon; D H Jones; J T Kemshead; H B Coakham
Journal:  Eur J Nucl Med       Date:  1986

5.  Superselective intracerebral chemotherapy of malignant tumours with BCNU. Neuroradiological considerations.

Authors:  J Théron; J G Villemure; C Worthington; J L Tyler
Journal:  Neuroradiology       Date:  1986       Impact factor: 2.804

6.  Delivery of hexosaminidase A to the cerebrum after osmotic modification of the blood--brain barrier.

Authors:  E A Neuwelt; J A Barranger; R O Brady; M Pagel; F S Furbish; J M Quirk; G E Mook; E Frenkel
Journal:  Proc Natl Acad Sci U S A       Date:  1981-09       Impact factor: 11.205

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.